Kidd, M <br/><br/>
The CCK(2) receptor antagonist, YF476, inhibits Mastomys ECL cell hyperplasia and gastric carcinoid tumor development.  [electronic resource] 

 -  Regulatory peptides  Jun 2010 
 - 52-60 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-1686 
<br/><br/><label>Standard No.: </label>10.1016/j.regpep.2010.01.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Benzodiazepinones--pharmacology<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Hyperplasia--prevention & control<br/>Male<br/>Murinae<br/>Phenylurea Compounds--pharmacology<br/>Polymerase Chain Reaction<br/>Receptor, Cholecystokinin B--antagonists & inhibitors<br/>Serotonin--metabolism<br/>Stomach Neoplasms--pathology